Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK-0941 Dose-Ranging in T2DM on Insulin
NCT00767000Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Oct 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of mk-0941 in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Oct 2008; status: terminated.
02
Drugs
mk-0941
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00767000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767000.